Biovator and BASF Sign Technology Development Agreement

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

Back to news